(Q92367919)

English

Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease

scientific article published on 19 February 2019

Statements

Real-world efficacy of adalimumab and infliximab for refractory intestinal Behçet's disease (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit